scispace - formally typeset
D

Daniel J. Siebert

Publications -  4
Citations -  1188

Daniel J. Siebert is an academic researcher. The author has contributed to research in topics: κ-opioid receptor & Salvinorin A. The author has an hindex of 4, co-authored 4 publications receiving 1122 citations.

Papers
More filters
Journal ArticleDOI

Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

TL;DR: Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for κ opioid receptors and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
Journal ArticleDOI

Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.

TL;DR: Salvinorin A was found to be a full agonist, being significantly more efficacious than (trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl] benzeneacetamide methane-sulfonate hydrate (U69593) and similar in efficacy to dynorphin A (the naturally occurring peptide ligand for κ-opioid receptors).
Journal ArticleDOI

Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.

TL;DR: In vitro pharmacological activities on receptors expressed in Chinese hamster ovary cells and in vivo antiscratch and antinociceptive activities in mice are investigated and salvinorin A, TRK-820, and 3FLB caused internalization of the human KOR in a dose-dependent manner.
Journal ArticleDOI

Antinociceptive and Hypothermic Effects of Salvinorin A Are Abolished in a Novel Strain of κ-Opioid Receptor-1 Knockout Mice

TL;DR: It is demonstrated that salvinorin A is the active component of S. divinorum, selective for κ1-opioid receptors, and that salvinegorin A and specific structurally related analogs produce behavioral effects that require the κ-opIOid receptor.